3-Bromo-7-nitroindazole - CAS 74209-34-0
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
C7H4BrN3O2
Molecular Weight:
242.03
COA:
Inquire
Targets:
Nitric oxide synthase (NOS)
Description:
3-Bromo-7-nitroindazole has been found to be a nNOS inhibitor and could also be a neuroprotective compound that inhibits the endoplasmic reticulum stress pathway.
Purity:
≥98% by HPLC
Appearance:
Light Brown Solid
Synonyms:
3-Bromo-7-nitro-1H-indazole
MSDS:
Inquire
InChIKey:
NFSTZPMYAZRZPC-UHFFFAOYSA-N
InChI:
InChI=1S/C7H4BrN3O2/c8-7-4-2-1-3-5(11(12)13)6(4)9-10-7/h1-3H,(H,9,10)
Canonical SMILES:
C1=CC2=C(NN=C2C(=C1)[N+](=O)[O-])Br
1.Effects of intrathecal administration of nitric oxide synthase inhibitors on carrageenan-induced thermal hyperalgesia.
Osborne MG;Coderre TJ Br J Pharmacol. 1999 Apr;126(8):1840-6.
1. We examined the effects of various nitric oxide synthase (NOS) inhibitors on carrageenan-induced thermal hyperalgesia. 2. First, we determined the time point at which a subcutaneous plantar injection of carrageenan into the rat hindpaw produced maximum thermal hyperalgesia. Subsequently, we demonstrated that intrathecal administration of the non-selective NOS inhibitor L-N(G)-nitro-arginine methyl ester (L-NAME) produces a dose-dependent reduction of carrageenan-induced thermal hyperalgesia. 3. Four relatively selective NOS inhibitors were then tested for their efficacy at reducing carrageenan-induced thermal hyperalgesia. Initially, the effects of prolonged treatment with inhibitors of neuronal [7-nitroindazole (7-NI) and 3-bromo-7-nitroindazole (3-Br)] and inducible [aminoguanidine (AG) and 2-amino-5,6-dihydro-methylthiazine (AMT)] NOS were examined. All agents were injected three times intrathecally during the course of inflammation caused by the plantar injection of carrageenan, and thermal hyperalgesia was measured at 6 h post-carrageenan using a plantar apparatus. 4. All inhibitors, except for 7-NI, were effective at attenuating the carrageenan-induced thermal hyperalgesia when compared with vehicle treatment.
2.The nitric oxide/cyclic GMP system at the supraspinal site is involved in the development of acute morphine antinociceptive tolerance.
Xu JY;Hill KP;Bidlack JM J Pharmacol Exp Ther. 1998 Jan;284(1):196-201.
The role of the supraspinal nitric oxide (NO)/cyclic GMP system in the development of acute morphine antinociceptive tolerance was investigated by use of the mouse 55 degrees C warm-water tail-flick test. A single intracerebroventricular (i.c.v.) pretreatment of mice with morphine (3 nmol, 140 min before testing) produced an acute antinociceptive tolerance to subsequent i.c.v. doses of morphine, as demonstrated by a 120-fold rightward shift of the morphine dose-response curve. When co-administered with morphine (140 min before testing), the NO synthase inhibitors: N-nitro-L-arginine methyl ester (L-NAME), 3-bromo-7-nitroindazole, 7-nitroindazole and NG-monomethyl-L-arginine, attenuated the development of morphine tolerance. All four NO synthase inhibitors completely blocked the rightward shift of the morphine dose-response curve caused by i.c.v. morphine pretreatment (3 nmol, 140 min before testing). This effect was partially antagonized by L-arginine, but not D-arginine, in a dose-dependent manner. Also, D-NAME did not block the development of tolerance. Like the NO synthase inhibitors, LY-83,583, a guanylyl cyclase inhibitor, blocked the development of tolerance, which suggests that NO acting through the cyclic GMP pathway is involved in the development of acute antinociceptive tolerance.
3.Possible role of nitric oxide in the development of L-2-chloropropionic acid-induced cerebellar granule cell necrosis.
Widdowson PS;Gyte A;Simpson MG;Farnworth M;Dunn D;Moore RB;Wyatt I;Lock EA Br J Pharmacol. 1996 Apr;117(8):1761-7.
1. L-2-Chloropropionic acid (L-CPA) produces selective neuronal cell necrosis in rat cerebellum when administered orally at 750 mg kg-1 that is mediated in part through activation of N-methyl-D-aspartate (NMDA) receptors. Cerebellar granule cell death occurs between 30 and 36 h following L-CPA administration exhibiting a number of features in common with excitatory amino acid-induced cell death. We have used this in vivo model to examine the neurochemical processes following L-CPA-induced activation of NMDA receptors leading to neuronal cell death in the rat cerebellum. 2. The effects of a number of compounds which potently block nitric oxide synthase in vitro were examined on L-CPA-induced neurotoxicity 48 h following L-CPA dosing, to discover whether the neuronal cell death is mediated in part by excessive nitric oxide generation. Four inhibitors were studied, NG-nitro-L-arginine (L-NOARG), NG-nitro-L-arginine methyl ester (L-NAME), NG-iminoethyl-L-ornithine (L-NIO) and 3-bromo-7-nitroindazole (BrNI). 3. L-NAME (50 mg kg-1, i.p. twice daily) and BrIN (50 mg kg-1, i.p. twice daily) administration prevented the L-CPA-induced loss of granule cells which can reach up to 80-90% of the total cell number in rats treated with L-CPA alone.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Nitric oxide synthase (NOS) Products


CAS 1071-37-0 EIT hydrobromide

EIT hydrobromide
(CAS: 1071-37-0)

EIT hydrobromide is a potent and reversible inhibitor of isoform II NO synthase (IC50 = 13 nM; approximately 20- and 30-fold selective over isoforms I and III r...

CAS 53308-83-1 L-NMMA acetate

L-NMMA acetate
(CAS: 53308-83-1)

L-NMMA is the archetypal competitive NOS inhibitor of all three NOS isoforms.

CAS 150403-89-7 L-NIL hydrochloride

L-NIL hydrochloride
(CAS: 150403-89-7)

L-NIL hydrochloride is a nitric oxide synthase inhibitor with IC50 value of 3.3 μM.

CAS 25371-96-4 TRIM

TRIM
(CAS: 25371-96-4)

TRIM is a potent inhibitor of neuronal and inducible NO synthases (nNOS and iNOS), but exhibits lower affinity for the endothelial isoform (IC50 = 28.2, 27.0 an...

CAS 56-06-4 2,4-Diamino-6-hydroxypyrimidine

2,4-Diamino-6-hydroxypyrimidine
(CAS: 56-06-4)

2,4-Diamino-6-hydroxypyrimidine has been found to be a GCH1 inhibitor and could suppress the activity of NO synthase through preventing the synthesis of BH4.

CAS 2219-31-0 L-Canavanine sulfate

L-Canavanine sulfate
(CAS: 2219-31-0)

The sulfate salt form of L-Canavanine, a homoserine analog, has been found to be a NO synthase inhibitor.

CAS 2482-00-0 Agmatine sulfate

Agmatine sulfate
(CAS: 2482-00-0)

Agmatine sulfate, the sulfate preparation of Agmatine, is an endogenous agonist at imidazoline receptor and a NO synthase inhibitor. Agmatine displaces clonidin...

CAS 159190-44-0 L-NIO dihydrochloride

L-NIO dihydrochloride
(CAS: 159190-44-0)

L-NIO dihydrochloride is a nitric oxide synthase inhibitor. It can inhibit iNOS, eNOS and nNOS. Active in vivo.

Chemical Structure

CAS 74209-34-0 3-Bromo-7-nitroindazole

Quick Inquiry

Verification code

Featured Items